"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
Descriptor ID |
D000369
|
MeSH Number(s) |
M01.060.116.100.080
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 83 | 83 |
1995 | 0 | 110 | 110 |
1996 | 0 | 127 | 127 |
1997 | 1 | 128 | 129 |
1998 | 0 | 142 | 142 |
1999 | 0 | 154 | 154 |
2000 | 0 | 161 | 161 |
2001 | 0 | 175 | 175 |
2002 | 0 | 233 | 233 |
2003 | 1 | 345 | 346 |
2004 | 1 | 337 | 338 |
2005 | 0 | 402 | 402 |
2006 | 0 | 443 | 443 |
2007 | 0 | 446 | 446 |
2008 | 0 | 524 | 524 |
2009 | 0 | 512 | 512 |
2010 | 0 | 602 | 602 |
2011 | 0 | 659 | 659 |
2012 | 0 | 687 | 687 |
2013 | 0 | 693 | 693 |
2014 | 0 | 722 | 722 |
2015 | 1 | 767 | 768 |
2016 | 0 | 697 | 697 |
2017 | 0 | 732 | 732 |
2018 | 0 | 734 | 734 |
2019 | 0 | 665 | 665 |
2020 | 0 | 601 | 601 |
2021 | 0 | 446 | 446 |
2022 | 0 | 94 | 94 |
2023 | 0 | 72 | 72 |
2024 | 0 | 14 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Improved Symptom Change Enhances Quality of Dying in Patients With Advanced Cancer: An East Asian Cross-Cultural Study. Oncologist. 2024 Apr 04; 29(4):e553-e560.
-
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clin Cancer Res. 2024 Apr 01; 30(7):1273-1280.
-
Case 9-2024: An 84-Year-Old Man with a Fall. N Engl J Med. 2024 Mar 21; 390(12):1129-1139.
-
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study. Lancet Haematol. 2024 Apr; 11(4):e276-e286.
-
Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair. J Am Heart Assoc. 2024 Mar 05; 13(5):e032784.
-
Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis. J Am Coll Cardiol. 2024 Feb 06; 83(5):577-591.
-
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open. 2024 Feb 05; 7(2):e240260.
-
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study. Lancet Haematol. 2024 Mar; 11(3):e186-e195.
-
Thrombectomy With the pRESET vs Solitaire Stent Retrievers as First-Line Large Vessel Occlusion Stroke Treatment: A Randomized Clinical Trial. JAMA Neurol. 2024 Feb 01; 81(2):170-178.
-
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology. 2024 02 27; 102(4):e208091.